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The life and work of Leiper and Leishman was celebrated in a Symposium in January 2016 
(Glasgow Encounters with Tropical diseases). This symposium has stimulated us to record our 
personal experiences in our research in schistosomiasis and other parasites which for all scientists 
herein has occupied a lifetime. Our aim is to show the way research ϐlourishes or ϐlounders and 
the different emotions which discoveries can generate. The role of serendipity is well represented. 
The scientiϐic themes are described in some detail and include the host antigen hypothesis, the 
surface membrane, the hygiene hypothesis, the immunology of human infections, heterologous 
and concomitant immunity, snail control and immunity, mechanisms of drug action, the excretory 
system, the oesophagus and feeding of the adult worm, immuno-diagnosis and vaccine production. 
We conclude that the awe and wonder about the living parasite and its interaction with the host is a 
major element in the experiences of the scientists involved. Students and close colleagues also play 
essential roles.
1 SUMMARY
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The discoveries of Leiper, celebrated in the Glasgow Symposium in January 2016, have been 
carefully and imaginatively described by [1]. The account by [2], has also gripped our imagination. 
Leiper’s success was helped by his doggedness and thorough methods and also relied on the help 
he was given by Miyairi and Suzuki, the Japanese scientists he met in 1914. All this has stimulated 
us to assemble some personal accounts of discoveries in the ϐield of schistosomiasis and other 
parasitic diseases. Each scientiϐic worker has been asked to give an account of their work in the 
form of a story, as an adventure, in which the thoughts of the scientist at the time of the research 
are made clear. This is so that we can understand the history of the discovery, the effects that the 
work has on the scientist, and in some cases the visions which ϐlow from the activity. We wish 
to portray research as a dynamic and very personal affair. Personal emotions during scientiϐic 
research are not often recorded in historical accounts but it is clear from the stories given here and 
that of [2], that scientists are very caught up in emotions during and after discovery. In this article 
examples are drawn from scientists who have made signiϐicant discoveries in schistosomiasis 
and other parasitic diseases.
The discovery
All scientists have made an observation that illuminates their lives. This revelation concerns 
the problem they are tackling and is both an intellectual and an emotional experience. It may 
come after a great deal of worry and the search for an answer can be incubated for a very long 
time. From this observation a whole world of ideas and experiments suggest themselves and I 
form a hypothesis. 
Testing the hypothesis
This is the essence of the scientiϐic approach and when I do this I am conscious of a highly 
exciting intellectual activity. I am also conscious that I may be attaching some emotion to my 
commitment to this hypothesis. I may feel “certain” that I am on the right track-this can mislead 
the scientist and often scientists are unwilling to renounce their own ideas.
In this activity, an “Act of faith” is necessary for the immense intellectual and physical 
effort required to complete the necessary work. The formulation of the hypothesis often has 
involved a creative intuition and the choice of subject may involve a great feeling of compassion 
and emotion. This idea has been well described and discussed in Michael Polanyi’s “Personal 
Knowledge” (especially under “Intellectual Passions” Polanyi) So the scientist is certainly using 
spiritual qualities, committing the whole of him/her self.
Scientiϐic colleagues
The interaction with friends and colleagues is an essential activity during the agony of 
2 INTRODUCTION
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hypothesis testing even the discovery itself. Close and warm personal interactions may be crucial in the 
resolution of the problem. These dialogues are vital and are the very essence of science and depend on 
personal encounters.
A critical approach
The best scientists are those that can ruthlessly criticise their own ideas, and strive to prove them 
incorrect. But the commitment described above must always be there to drive the hard work and effort.
The way
Thus the scientiϐic method described above is deeply ingrained in the scientist and is the way, the path to 
truth about the material Universe. This way has been very successful, and is so valuable because error in the 
interpretation can be rapidly eliminated due to continuous discussion and revision and further experiment. 
Humility is essential in a good scientist, because he/she must value and be open to the work of others.
Scientiϐic hypotheses which do not fail are termed theories or laws although all scientists recognise that 
these can be modiϐied with further experimentation [3]. Prefers the word “habit” to law in a stimulating 
critique of the dogmas of modern science.
We describe below how this process actually operates in the lives of the scientists who were kind enough 
to contribute to this paper.
Kusel writes
My PhD supervisor was Don Northcote in Plant Biochemistry, Biochemistry Department and Tennis 
Court Road Cambridge University [4].
Don Northcote, as an initiation into scientiϐic research, gave me advice which I have never forgotten. 
“Follow your results” was his research philosophy, and I have incorporated this in my research, and advised 
others to do the same. This phrase removes the rigidity from scientiϐic investigation, and later, a friend and 
colleague from France, Helene Mone, exhorted us to “look, and look and look”. This is similar to the “take 
time to look” of Barbara McClintock and the “take a closer look of Leiper himself. I like to add “make your 
own mistakes” and do not be frightened to make them because doing this is a potent way of investigating 
unknown areas.
During the research I had come across heavy staining using the Gomori histochemical technique for 
phosphatases, in some internal membranes of the pea root cells. This encouraged me to work on “Plant Cell 
Membranes” for my PhD thesis, a subject which had not been entertained by Don thus far in his laboratory. It 
was an exciting project and I was given complete freedom to make my own mistakes and to try out my ideas. 
This experience was a harsh teacher, because many things I tried did not bear fruit and I published nothing 
from this work. However, this sense of freedom gave me a sense of adventure, and the independence taught 
me to think on my own and with conϐidence.
During research for the PhD degree I had yearned for some practical use for my studies and had thought 
about studying medicine. Joseph Ndabahweje, the technician from Uganda working in Don’s laboratory, 
suggested that I should think about working on a disease called Bilharzia or schistosomiasis as it is more 
usually called now. In Uganda and many other African countries, Bilharzia (schistosomiasis) is a very 
common disease transmitted by water snails and I had never heard of it!
In the 1960’s there were no good drugs against schistosomiasis, (or bilharzia), the suffering was 
considerable and visits to the Pediatric ward in Khartoum Civil Hospitable was heartrending. We felt tearful 
compassion, especially for those very heavily infected. This was the beginning of action and discovery and 
the practical application of science that I had missed during University education. 
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We started work on the disease by establishing a snail colony in the laboratory and infecting the snails 
with the eggs from faces obtained from patients from the hospital.
Since the eggs were very readily available, my ϐirst studies were directed towards the nature of 
the structure of the egg and its mode of hatching. This research was carried out by the use of the light 
microscope and involved very simple observations and ideas drawn from these. One strange phenomenon 
in the structure of the egg, as seen under the microscope is a balloon-like body. The nature of this was 
completely unknown, so I attempted to reveal, by immersing the egg in solutions of increasing density of 
albumin, the internal structure of the balloon. I concluded that it was cellular and was the remains of the 
vitelline cells which are used for nourishment. I also wanted to determine how the egg hatched, since the 
egg shell appeared to break open at random regions, unlike the egg shell of some other worms such as the 
liver ϐluke. I examined hundreds of hatching eggs and open egg shells, and investigated number of stains to 
highlight the broken region. I concluded that there was no clear region which showed the initial weakness. 
It was also possible to initiate the hatching in dead eggs by the use of osmotic stress caused by glycerol.
All these experiments may seem very simple but for me, new to the ϐield, they were very exciting. The 
observations were novel and I published the observations, my ϐirst paper ever (Kusel 1970). I received news 
of the successful review of this paper with news of another paper that I had submitted on the penetration 
of human skin by the cercariae to produce schistosomula. I recount these stories because the editor of the 
journal “Parasitology” took great pains to point out the Latin origin of the word schistosomulum, (originally 
from the Greek skistos and soma) and this gentle caring scholasticism in editorial comments (the Editor was 
Professor H.D. Crofton) would be most welcome in these modern times and made a lasting impression on 
my attitudes towards the attempts of others to publish new ϐindings!
I made an observation when looking at the schistosomula produced during skin penetration. They 
showed a strong binding over their surfaces to isolated erythrocytes which had strayed into the human 
serum which I was using to collect the schistosomula. At this time I had visited Ron Smithers at Mill Hill and 
he had outlined the work they were doing there and I was able to discuss my plans. He and his group had 
shown that the schistosome acquires host antigens on its surface. This was in contrast with the experiments 
of Andre Capron and his group, who speculated that the host antigens were synthesised by the parasite. 
When I observed the binding of the erythrocytes to the surfaces of the schistosomula, I jumped to the 
conclusion that here was a possible method by which the host antigens could be transferred to the parasite! 
Very much later this idea was conϐirmed when I was working with the Smithers’ group. (I mention this, not 
to claim any priority, but to show that ideas can be sown as a seed by observations which have no direct 
relevance at the time).
Again, later work showed that Capron was also correct and that some host antigens can be synthesised 
by the parasite. This is often found in science where two apparently opposite views reϐlect the unexpected 
complexity of living organisms.
The host antigen hypothesis 
In about 1968 Ron Smithers and Roland Terry had evidence that the schistosome tissues contained host-
like molecules. At a meeting of the BSP a colleague suggested that these might be acquired from host serum. 
Smithers and Terry immediately set up experiments to detect the presence of host molecules on the surface 
of the adult parasite. Rhesus monkeys were immunised with mouse serum proteins and adult schistosomes 
from infected mice were transferred by a surgical procedure into the portal veins of the monkeys. Monkeys 
without immunisation were used as controls. After several weeks, to allow the transplanted worms to 
adapt, the monkeys were perfused and adult worms recovered from the portal system.
The number of worms recovered from the immunised monkeys was signiϐicantly less than those 
recovered from the control monkeys. This was evidence that the worms grown in the mice carried mouse 
macromolecules on the surface and these were detected by monkey antibodies which destroyed the worms 
[5].
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After many experiments it was clear that the surface membrane appeared to carry the host molecules. 
What were these host antigens doing? Clegg, who joined Smithers in 1968, designed experiments to test the 
hypothesis that the host antigen acted as an immunological disguise, and obscured parasite antigens from 
host antibody binding. Experiments were carried out using schistosomula cultured in the presence of serum 
and red blood cells and there was a clear correlation between the uptake of antigens from the red blood 
cells and the lack of binding of anti-parasite antibodies to the cultured schistosomula.
It was very unclear as to how the host antigens were acquired. I urged John Clegg to go with me to a 
seminar on serum complement binding to membranes to be given by Robin Hesketh (now also an author). 
A valuable feature of the atmosphere in Mill Hill was that there were many seminars on all subjects, and 
such seminars greatly stimulated interaction between Divisions of different biological disciplines. A good 
principle is to go to seminars which are not directly relevant to your own research problems. Often a spark 
can come from what you hear! Robin was concerned with measuring the binding of complement to artiϐicial 
lipid membranes. The insertion of antigens into the membrane involved incubating liposomes with the 
glycolipid Forsmann antigen. Antigen uptake occurred by insertion of the lipophilic tail into the membrane. 
This statement caused John and I to look at each other amazed and excited. This could be the way host 
antigens, in glycolipid form, might insert into the schistosome membrane! We had previously assumed 
that the host antigens were proteins. This “discovery” was greeted with excitement in the laboratory and a 
number of experiments were quickly designed to test the idea that the host antigens might be blood group 
glycolipids. Blood group glycolipids could be shown to be taken up in vitro by schistosomula during growth 
and incorporated into the surface membrane. The crux of the problem for the host antigen hypothesis was 
whether the recently acquired blood group substances actually prevented host immune mechanisms from 
damaging the parasite once it was realised that the red blood cell antigens might be blood group glycolipid 
substances, Owen Goldring [6], showed that glycolipids could be readily acquired from cells in culture [7]. 
Harnett showed a correlation between loss of red blood cell antigens from the adult worms and exposure 
of parasite antigens. Some scientists had shown that there was a decrease in host antibody binding to the 
parasite during prolonged culture even in the absence of any host molecules. Thus the changes in the surface 
membrane could be intrinsic and the acquisition of host antigens might be a totally separate phenomenon, 
based on physicochemical nature of the membrane itself! El Ridi and colleagues [8], have a very original 
study in which the biophysical nature of the surface is responsible for the lack of exposure of parasite 
antigens. They have shown that the change in metabolism of sphingomyelin in the surface membrane can 
account for a change in orientation of parasite membrane proteins.
The surface 
The work I was doing with the skin schistosomula enabled me to examine the differences between the 
surfaces of the cercaria and the schistosomulum. Using simple salt solutions to inhibit the dissolution of the 
surfaces by acid or alkali, I was able to speculate that the surfaces were stabilised by ionic forces and salt 
bonds Although modern studies of the surfaces [9], have deϐined the proteins and their location in these 
surfaces, we still have no idea of how the molecules are bound together, or inserted in a lipid membrane.
In order to explore the surface structure further we tested how easily the surface could be damaged by 
detergents. We came across avery unexpected ϐinding. The detergent digitonin caused the surface of the 
cercaria to swell and become fragile, but did not dissolve it. Digitonin was known to bind to cholesterol in 
membranes and so this surface seemed to partly consist of a conventional membrane. After pondering for 
a day or two, it suddenly struck me that it would be possible to use this treatment to isolate the membrane 
and perhaps use the preparation as a vaccine. I had previously been to see Ron Smithers in Mill Hill and met 
the gifted David Hockley, a superb electron microscopist. Professor George Nelson was visiting Khartoum 
the next week so I prepared surface membranes, ϐixed them in formaldehyde and gave them in a small tube 
to Professor Nelson.
David was able to produce some beautiful electron microscope sections of these surfaces and I was able 
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to publish our ϐindings in a paper which was the ϐirst to describe membrane isolation. In keeping with his 
self-effacing humility, David did not want joint authorship although I urged it, but wished only to be thanked 
in the acknowledgements.
The moment of realisation that the membrane could be isolated from this observation was a moment of 
discovery. Many ideas about the possibilities engrained in the discovery swept over me and I was extremely 
excited but calm. This moment is not important in the history of schistosomiasis, because other methods 
have been discovered since, but to me it gave me an insight into how creative scientists and other creative 
workers feel at the moment of discovery. Many strands of knowing and experience were involved in the 
process and thus it was intensely personal and the whole of me as a person was involved in it. I left Sudan in 
1970 and had the temerity to approach Smithers to see if I could work in his laboratory for the summer. He 
agreed! I started work and immediately noticed the atmosphere of imagination, good personal relationships 
full and frank discussion and hard work.
I continued the work I had initiated in the Sudan, and tried to reproduce the results I had obtained 
with cercariae and schistosomula, in which the surface could be isolated using saponin or digitonin. It was 
quickly found that saponin, especially with the addition of calcium ions, could be used to strip off the outer 
tegument of the adult male and female parasite and thus could be a basis for the isolation of the surface 
membrane. I read this as a paper (my very ϐirst!) at the Spring Meeting of the British Society for Parasitology 
(1970). I had prepared the talk with the help of John Clegg and Ron Smithers, but this did not prepare me 
for the storm of adverse questions which followed my talk. The main problem was that I claimed to have 
isolated the tegument of the larval and adult stages, but quite correctly one of the Electron Microscopists 
in the audience objected (Dr Kate Lyon in the very front seat!), that it was only the membrane that had 
been isolated. To call it tegument was incorrect. Another criticism was that saponin would destroy the 
phospholipids in the membrane itself, so the criticism hit both ways! I was chastened and resolved to be 
more precise in terminology and in preparation for questions in the future. I subsequently found a way to 
isolate the membrane by a freezing and thawing technique, which is still used to isolate membranes prior to 
the determination of the protein architecture of the membrane [9].
In Glasgow University the development of the research programme, I tended to follow the words of 
Don Northcote “follow the Results” This meant that apart from the necessity of planning for the writing of 
grant applications, the progress depended on intuitive processes stimulated by observation. This suited 
my way of working but it was puzzling to others and it did not make me a great group leader or principal 
investigator, because I was considerably dependent on the observations I myself, made in the laboratory. 
Our small group consisted of Lesley Stones, Batool Al-Adhami and Joyce Thornhill. We were joined by Janet 
Jones who introduced an interest in genetics and then by Billy Harnett. Later we welcomed Leda Vieira from 
Brazil.
My philosophy was to encourage each to have their own project and I worked away on my own ideas. 
Lesley was my technician although she was encouraged to work with others since we had a ϐlexible system. 
Joyce Thornhill was responsible for the maintenance of the snail colony and her powers of observation 
were such that she developed her own research project on the laying of eggs by infected snails.
Billy Harnett writes about discovery in this way
My understanding of the excitement of discovery only really emerged during my PhD studies. I had been 
an undergraduate student on the BSc in Immunology course at the University of Glasgow and during the 
ϐinal (Senior Honours) year a major component of the course was the undertaking of a lab-based project. 
Fortunately, one was able to select a project from a list which is offered by members of staff and I chose to 
work with Dr John Kusel in the Department of Biochemistry on a project entitled “Investigation to explain 
non-adhesiveness of the surface membrane of adult Schistosoma mansoni for mouse peritoneal cells”. 
My interest in parasitic worms like schistosomes was a consequence of the very ϐirst lecture I attended 
at Glasgow: It was delivered by Dr Adrian Hopkins who described tapeworms in a highly entertaining 
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discourse on the gut. When I arrived at Glasgow my intention had been to specialise in Chemistry but I was 
so impressed by this lecture that I ended up switching to Immunology. 
Undaunted by my idiosyncratic performance during my Honours project, John sounded enthusiastic 
when I broached the subject of a PhD. John thus submitted a grant application to the MRC but unfortunately 
this was unsuccessful. I thus accepted a Research Assistant position at Glasgow Royal Inϐirmary to work on 
detecting carcinoembryonic antigen by radioimmunoassay (RIA) and this also had the carrot of working 
towards a PhD thrown in. However, the position largely involved routine clinical immune-diagnosis and so 
when John informed me that a resubmitted grant application was successful, the opportunity to go back to 
research into the immunology of parasitic worms proved too strong a lure to resist and thus I returned to 
his lab after one year at the Royal Inϐirmary. Interestingly however, what I had learned on the subject of RIA 
during this year proved to be key to the research I was subsequently to undertake during the next few years.
My PhD was related to my Honours project in focusing on the schistosome surface membrane. This is a 
very intriguing structure, electron microscopy revealing that it was unusual, indeed unique, in consisting 
of a double lipid bilayer. Furthermore, the outer bilayer was known to contain molecules, which had 
been acquired from the parasitized host. These were largely glycolipids found on red blood cells and it 
was considered that they acted to disguise the schistosome from antibody-mediated immunity (the “host 
antigen” hypothesis, put forward by Ron Smithers and Roland Terry). The focus of my research was to 
investigate aspects of this hypothesis and in particular, to determine if it was possible to expose parasite 
antigens that could act as targets for antibody by interfering with the host antigen coat. Towards this, 
antibodies were already available in John’s lab against both parasite and host antigens and it was possible 
to detect binding of these reagents by indirect immunoϐluorescence (IF). However, on starting to explore 
this system, I quickly realised that a more quantitative assay was required (the IF procedure only being 
semi-quantitative) and I therefore decided to use my previous experience to develop an RIA. 
This proved to be more challenging than expected, in particular a great deal of work on optimisation 
was required, but eventually I managed to design an indirect radiolabelled antibody method (the “IRMA”) 
that was able to quantify the binding of both antisera to the living schistosome surface using I-conjugated 
second antibodies. The question then was would I be able to perturb the membrane in some way to reduce 
expression of host antigens and at the same time promote increased expression of parasite antigens 
and equally importantly, would my assay be able to measure the change? Again, this took some time but 
eventually I was able to achieve success simply by using formaldehyde–I found that exposure of adult male 
worms to this reagent decreased expression of host antigens and increased exposure of parasite antigens. 
Within the Biochemistry Department, there was a little bench-top gamma counter, which I had virtually 
commandeered for my own use and I still remember clearly the feeling of exhilaration standing watching 
the ϐirst positive data emerge from the gamma counter’s printer (~09.25 in the evening and I think it was 
a Tuesday….). 
Following this, inspired by Mike Doenhoff who had published on the interaction between anthelmintics 
and the immune system, I went on to show that the key anti-schistosome drug praziquantel, whose 
mechanism of action wasn’t fully understood, also exposed parasite antigens at the schistosome surface. 
This was a potentially important ϐinding with respect to chemotherapy. 
Leda Vieira writes on the topic of discoveries
Serendipity is probably the word that best describes my most successful research. I have always 
worked on immunology of parasitic diseases, but the roots of the Department where I did my PhD-and 
now work at-are in Biochemistry. Therefore, I have always had a sentimental link to the Brazilian Society 
for Biochemistry and Molecular Biology. In order to attend the meeting, I would send papers on teaching 
Biochemistry (which I teach to undergraduate courses). One year, a group of students taking a practical 
course in Biochemistry decided to investigate the production of reactive oxygen species by macrophages 
from the several knockout mice I had in my lab. They did the experiments and some interesting results 
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were produced. Instead of taking my poster to the Education section, I dared and took it to the Free Radical 
section. There, I met two prominent researchers in the ϐield, who criticized the poster severely. One was 
interested in doing some experiments with knock-out mice for the phagocyte NADPH-dependent oxidase 
(phox ko) infected with Trypanosoma cruzi and proposed that we did them together, since I had the capacity 
of keeping immunosuppressed mice successfully. We did these experiments in collaboration, and found 
that, when infected with T. cruzi, parasitemia is the same in wild-type and phox ko mice and so is organ 
parasitism. However, mortality was much higher in phox ko mice. In fact, they died as quickly due to 
infection as the highly susceptible interferon-γ ko mice. However, interferon- γ ko mice had a much larger 
parasitemia. So, phox ko mice controlled parasite growth but also died in the acute phase of the infection. 
What was killing them? As it turned out, it was an excess of nitric oxide and consequent low blood pressure. 
When present in equimolar concentrations, nitric oxide and superoxide react and produce peroxinitrite, 
which has no effect on the blood pressure, albeit toxic to the parasite. In phox ko mice, superoxide was 
not present to react with nitric oxide. Thus, nitric oxide from phagocytes that were activated to kill the 
parasites (hence producing nitric oxide) was active in lowering blood pressure (Santiago et al., 2012). I was 
subsequently invited to be a part of a National project on Redox Biology by the second researcher I met 
at that meeting. Since then, our lab has produced thesis and papers on the subject. Had I not gone to the 
Free Radical section of the meeting and had I not attracted the criticism of the two experts, I would have 
never entered this ϐield, which has been indeed gratifying. Interestingly, part of my PhD thesis was also 
done using two techniques that were introduced to the lab by serendipity. I worked with surface vesicles 
of schistosomula from Schistosoma mansoni that were obtained because my supervisor (Professor Kusel) 
had unintentionally added hyperosmotic saline to the parasites (and actually looked at them under the 
microscope instead of discarding them) (Vieira et al., 1987).
Skin schistosomula 
On several occasions during incubation of mechanically derived schistosomula [10], with ϐluorescent 
membrane-impermeant dextrans, we noticed that a small proportion of living undamaged schistosomula 
were labelled in their excretory tubules. How did the large molecules enter the schistosomula? The 
membrane was thought to be impermeable to proteins and dextrans. By a coincidence of observations we 
hastily jumped to the conclusion that the large molecules had entered through the nephridiopore. We had 
noticed during in vitro investigations with the adult worm that during damage to the surface, ϐluorescent 
dextrans and serum albumin entered the nephridopore. In other experiments, damage to the schistosomula 
surface gave heavy labelling in the region of the excretory region. So we were open to the idea that entry of 
molecules could occur by this pathway. This suggestion was resisted by many of my colleagues, vigorously 
so in some instances! I mention this because it is easy to see a certain path where another may exist. Eager 
to test this hypothesis, we transformed schistosomula by the syringe method in the presence of a variety of 
membrane impermeable compounds (dextrans, proteins, propidium iodide). A proportion of schistosomula 
showed uptake concentrated in the excretory region. All data was consistent with the nephridiopore being 
the route of entry. Fluorescent poly-l-lysine was localised in the excretory tubules and bladders so we 
felt conϐident that this could be the correct interpretation. But an alternative explanation not considered 
initially was that large molecules could enter the schistosomulum through the surface membrane itself.
We studied the uptake of large membrane impermeable compound when injected into the pathway of 
penetrating cercariae during passage through the skin of mice. There was massive uptake into the body of 
the schistosomula and not only in the excretory region.
When we repeated the experiment by injecting ϐluorescent dextrans and the endocytosis marker FM 
143, into the region of penetration of mice 24 hours and 48 hours after infection, a similar massive uptake 
of dextran and of FM143 occurred. This suggested strongly that the molecules had penetrated through the 
surface membrane during their residence in the skin. These in vivo labelling patterns were not observed 
during in vitro.
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We were very excited by this because it seemed that passage and migration through the skin induced 
a great increase in membrane activity. Could this also be true in other parasites? Perhaps trypanosomes, 
malaria [11] and nematodes [12], experience similar changes in their surfaces during residence in the skin.
Thus in this section we have seen that hypotheses have been suggested due to hunches and that these 
have sometimes led the scientist astray and to pursue work on the hypotheses even though evidence was 
incomplete. This is an example of resistance within the scientist himself [13].
The excretory system 
The observations of Fabio Ribeiro [14], had sensitised us to “look for” phenomena involving the excretory 
tubules. We came across an example of this when looking for hydrogen peroxide in the adult worm using 
the dye Amplex Red, which liberates the highly ϐluorescent resoruϐin in the presence of hydrogen peroxide 
and peroxidase. To our amazement the resoruϐin was concentrated in the excretory tubules and ejected 
from the worm through the nephridiopore. Resoruϐin is part of a family of molecules which are recognised 
by the P glycoproteins which excrete drugs from drug resistant cancer cells. This led us to hypothesise that 
P glycoproteins were concentrated in the excretory tubules. Thus the excretory system might be a means 
by which the parasite excreted drugs, importantly praziquantel. This is being exhaustively studied by the 
laboratory of Bob [15]. Currently no concentration of P-glycoproteins has been detected in the excretory 
tubules, so our explanations may be too simple!
Donato Cioli writes as follows
I entered the ϐield of parasitology through a rather uncommon door, i.e. on the basis of a rational free 
choice. Back in 1968 (and the date says a lot), I was one of a group of young postdocs at the Salk Institute 
(La Jolla, CA) who engaged in a collective discussion about the social meaning of our research and, after 
laborious study and lengthy consultation, decided to re-orient the contents and the goals of our work1. In our 
bold excursus of the most pressing needs of mankind, we came across a parasitic infection, schistosomiasis 
that affected 200 million people, was mainly prevalent in poor countries and appeared to be under-studied 
and–powerful motivation– was also biologically fascinating. With the naive self-conϐidence of our age, we 
thought we could contribute to some of the most pressing needs in the ϐield (no vaccine, poor drugs and 
incomplete knowledge of the pathogen). As a result, four of us decided to devote our research efforts to 
that disease once we could establish our independent laboratories. This is what eventually Alan Sher did at 
NIH, Paul Knopf at Brown University, Italo Cesari in Caracas, Venezuela, and myself in Rome–a crew some 
jokingly labelled as “the La Jolla four”.
Inϐluenced by our previous training, most of us initially addressed the immunological aspects of the 
disease. At that time, the “host antigen” phenomenon described by Smithers and Terry was attracting a lot 
of attention and everybody’s goal was to ϐind ways to circumvent it. But at the same time, the idea of such a 
clever mechanism developed by the parasite almost unconsciously stimulated a sense of awe and admiration 
toward such a respectable enemy. I remember indulging oftentimes in a mute dialogue with those elegant, 
digniϐied, lively schistosomes I was observing at length under the microscope as if asking them to ϐinally 
disclose their secrets. The dream of a vaccine was irresistibly attractive: a radical prevention, possibly a 
way to interrupt transmission, no more repeated treatments, no more disease. Yet the challenges were 
enormous: only partial and very delayed acquired immunity in humans, disappointing and controversial 
results in experimental animals, a bafϐling array of potential but ineffective antigens. 
At some point, the goal of a vaccine seemed so distant in the future that maybe the disease would be 
sooner vanquished by other means–hopefully just by economic progress. In the meantime, disease control 
had made substantial progress with the introduction of safe and effective drugs, so that large numbers of 
people were actually experiencing signiϐicant, albeit not deϐinitive, health beneϐits. The ϐield of antiparasitic 
chemotherapy is ϐilled with a number of challenging problems, a crucial one being the fact that the mechanism 
of action of many drugs is often unknown, which makes the development of improved medications a largely 
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empirical process. As to schistosomiasis, the most signiϐicant discovery, after the elucidation of the life cycle 
(e.g., Manson’s work), has probably been the introduction of praziquantel, a drug capable of producing 
complete worm eradication with minimal side effects after a single oral dose. The main problem with 
praziquantel is the fact that, due to its success, it is practically the only available antischistosomal drug and, 
after decades of mass administration to millions of people, the danger of drug resistance is a serious threat. 
There is another antischistosomal drug that is as safe and effective as praziquantel, i.e. oxamniquine, but 
it has been practically abandoned because–unlike praziquantel–it is effective only against S. mansoni and not 
against the two other major schistosome species (S. haematobium and S. japonicum). I had been intrigued 
by a very similar drug, in fact a progenitor of oxamniquine, called hycanthone, whose mechanism of action 
appeared uniquely approachable due to the existence of schistosome strains that were highly insensitive 
to the drug. The obvious idea was that understanding the nature of the difference between sensitive and 
resistant parasites would give a crucial clue to the drug mechanism of action. The two schistosome strains–
sensitive and resistant–are remarkably stable, an immediate enticement to explore the genetic basis of 
their different behaviour. Among the possible ways to perform genetic crosses between schistosomes, I 
was particularly attracted by what appeared to be the most straightforward and cleanest approach, namely 
to mate a single male and a single female worm and analyse their progeny. When I was an apprentice in 
schistosomiasis, I had seen Ron Smithers performing his elegant worm transfers into the mesenteric veins 
of Rhesus monkeys and I had later adapted the technique to the size of mouse veins2. Thus, I resorted to this 
method to investigate the genetic basis of drug resistance in schistosomes. 
I wouldn’t have made much progress in this whole story without another fortunate circumstance, i.e. 
the precious collaboration with my long-time friend and colleague Livia Pica-Mattoccia. Together, we 
crossed sensitive and resistant schistosomes and from the analysis of F
1
 and F
2
 progeny, backcrosses 
and genetic complementation experiments, we got evidence that resistance was determined by a single 
autosomal recessive gene3. Discovering that schistosomes, like other metazoans and like humans, obey to 
good old classical Mendelian laws was not at all surprising from a scientiϐic point of view, yet it somehow 
strengthened a feeling of closeness and almost of friendship with those remarkable creatures.
The fact that resistance to hycanthone and oxamniquine was a recessive trait, immediately suggested 
that resistant schistosomes were lacking some critical factor, probably involved in a drug activation 
mechanism. Indeed, biochemical experiments showed that an extract of sensitive schistosomes rendered 
the drug capable of covalently binding to the DNA of parasites, whereas the equivalent extract from resistant 
worms failed to do so. Fractionation of the worm extract showed that the activating activity had a molecular 
weight of about 30kDa and that the activation reaction required the presence of a sulfate donor. Together 
with a number of additional pieces of evidence, we came to the conclusion that antischistosomal activity 
was dependent on the presence of a parasite sulfotransferase4, but we were unable to decide which one of 
a number of schistosome genes coding for sulfotransferases was the real protagonist. It was only with the 
help of cutting edge techniques of linkage mapping and crystallography provided by the collaboration with 
Phil LoVerde and Tim Anderson that the crucial gene (called Smp_089320) was unequivocally identiϐied5. It 
was indeed a sulfotransferase, thus vindicating a prediction we had made decades previously and providing 
us with one of the most gratifying feelings in the risky life of a scientiϐic researcher. 
Now that we know the molecular picture (in fact, the atomic details) of how oxamniquine binds to the 
activating sulfotransferase of S. mansoni, there are real possibilities of designing drug analogues that would 
bind to the orthologous genes of S. haematobium and S. japonicum, thus providing valid alternatives-or 
supplements-to the exclusive use of praziquantel. Work in progress in that direction is extremely promising, 
thus fulϐilling at least a minuscule portion of those juvenile dreams of doing research as close as possible to 
human needs.
Paulo Coelho writes
In the decade of 1970, Dr. Jose Rabelo Freitas (deceased in 2014), a reputed ecologist from Federal 
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University of Minas Gerais– Department of General Biology with many important contributions about 
ecology of snails genus Biomphalaria, transmitters of schistosomiasis mansoni in Brazil) and I were studying 
the susceptibility of geographical B. tenagophila strains from different regions in Brazil challenged with 
geographical strains of Schistosoma mansoni. Among dozens of B. tenagophila geographic strains we found 
one coming from Biological Reservoir in Taim, State of Rio Grande do Sul. This lineage was challenged with 
different strains of S. mansoni and with variable burdens of miracidia, showing always absolute resistance 
to infection [16]. B. tenagophila resistant lineage arouse in us a huge interest because this species is the 
second more important of genus Biomphalaria related to the transmission of schistosomiasis in Brazil.
A fundamental question was: Does S. mansoni resistance show dominant or recessive character? 
The cross-breeding between B. tenagophila Taim lineage and the B. tenagophila albino strain (recessive 
phenotype), highly susceptible to S. mansoni, resulted in an F1 generation totally resistant to the parasite. 
The F2 generation showed about 25% of susceptibility, clearly according to the classic Mendelian genetics 
[17].
Further studies demonstrated that the transference of hemolymph from Taim lineage to a susceptible 
strain resulted in a signiϐicant increase of the resistance from the receptor lineage against S. mansoni 
infection. The transplantation of the hematopoietic tissue from Taim lineage to another susceptible snail 
strain showed that there occurred an absolute resistance to the parasite in the receptor strain when the 
transplant became established. For this last experiment, we had a molecular marker represented by a 350 
base pairs band of the ribosomal RNA internal transcribed spacer region (ITS), which is peculiar to the Taim 
lineage. This marker allowed us to evaluate the success of the transplantation (the presence of haemocytes 
with the marker of 350bp demonstrated the success of hematopoietic tissue transplant) [18].
Other studies demonstrated that internal defense system of Taim lineage is responsible for Taim lineage 
resistance to S. mansoni. This mechanism is hugely efϐicient eliminating the parasite rapidly in in vitro 
and in vivo experiments through the confrontation of hematopoietic cells from Taim lineage with in vitro 
transformed S. mansoni sporocysts. In both cases, the sporocyst death occurs in a few hours (in vivo: less 
than 6 hours). It could be inferred that the absolute resistance of Taim lineage to S. mansoni is not due a 
simple incompatibility between parasite and invertebrate host but related to a sophisticated mechanism 
linked to the internal defense system of snail [19].
After decades of studies, these results allowed us to test the hypothesis that the introduction of this 
Taim lineage into endemic areas (in which B. tenagophila is known to be the transmitter of schistosomiasis 
[20], might decrease the transmission of the disease. Therefore, we obtained all environmental licenses 
for ϐield intervention. The breeding of Taim lineage in a mass scale is well stablished and has been used to 
produce many thousands of snails in the city of Bananal, State of Sao Paulo, in collaboration with Dr. Engels 
Maciel and support of SUCEN (Superintendência de Controle de Endemias de São Paulo) [21]. B. tenagophila 
Lineage Taim snails were introduced into the locality of Herivelton Martins stream that contained local 
snails with an average susceptibility of 30% before introduction of those of Taim lineage. After 15 months 
of the introduction, only 2.1% of the offspring snails, that resulted from crossbreeding between Lineage 
Taim introduced snails and local snails, were infected. Furthermore, it was observed that there was a 
strong correlation between the presence of the B. tenagophila Taim molecular marker in the offspring and 
resistance to infection by S. mansoni. Studies conducted in the area showed that during the occurrence of 
ϐloods, other tributaries of the watershed were connected with Herivelton Martins stream triggering the 
reintroduction of susceptible local snails in the ecosystem. Susceptibility tests in these condition showed 
15% of susceptibility of young snails and a reduction of the 350bp molecular marker in this population. New 
introductions will be conducted in the Herivelton Martins stream and in new susceptible B. tenagophila 
habitats of this region. These results have shown the difϐiculties and complexity of studies in natural 
environment. 
Recent studies of hematopoietic cell cultures (hemocytes) are been conducted as well as molecular 
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studies using bioinformatics tools, microRNA sequencing, transcriptome and genome sequencing of 
B. tenagophila Taim lineage aiming the identiϐication and isolation of the principal gene involved in the 
resistance. An ambitious purpose is to create a B. glabrata (most important species for schistosomiasis 
transmission in Brazil) resistant transgenic strain using transfection techniques to transfer the gene (s) of 
Taim lineage to B. glabrata. If this transgenic approach in B. glabrata works, the same approach could be 
used in other Biomphalaria species in the African continent, then all susceptible to S. mansoni. 
Alan Wilson writes
I have a vivid memory of my ϐirst encounter with schistosomes as a student at Imperial College (IC), when 
Dr John Jewsbury from the Natural History Museum, dissected out adult worms from the hepatic portal 
vein a mouse infected with Schistosoma mansoni. Little did I realise that event would shape my subsequent 
career. In 1962 I was offered a PhD studentship at IC with a free choice of topic and picked the liver ϐluke 
Fasciola hepatica, receiving external guidance from Dr Ollerenshaw at the Central Veterinary Laboratories 
in Weybridge. A lecture by Francis Crick on the genetic code convinced me that there was a lot of exciting 
work at the molecular end of biology about which I was woefully uninformed. In the then time-honoured 
way, I remedied that deϐicit at “night school”, a three-year Diploma in Biochemistry, at Chelsea College. 
In 1965 I took the train north to a building site called the new University of York and a post as Lecturer; I 
had complete freedom to develop both my undergraduate teaching and my own research inclinations. At 
York I built up a research group probably amounting over the years to ~90 post-graduates, post-doctoral 
fellows and visiting researchers, not forgetting the yearly intake of project students, ~150 in total. It would 
be invidious to single out individuals but their overall contributions were immense. Two colleagues, Dr 
Patricia Coulson (1972) and Dr Adrian Mountford (1985), eventually became permanent members of the 
Schistosomisis Research Group on University posts.
In the 1960s electron microscopy was the cutting edge technique, and whilst still a PhD student at IC, 
with the help from Dr Mary Morris, I obtained images of the liver ϐluke egg as part of a study of its hatching 
mechanism, using a microscope in the Department of Electrical Engineering. Fortunately the York Biology 
Department decided to invest in a new-fangled electron microscope suite, allowing me to explore the 
ultrastructure ϐirst of Fasciola and later of Schistosoma. In 1970, with help from Dr Ron Smithers at the 
National Institute of Medical Research in London, we set up the S. mansoni life cycle and I got my ϐirst MRC 
grant to investigate the schistosome tegument. 
Papers on tegument ultrastructure and function followed in 1974, documenting the existence of a 
secreted “membranocalyx” overlying the plasma membrane of the tegument syncytium, so initiating a 
lifelong fascination with immune evasion at this parasite-host interface. A meeting with Darwin Murrell 
in Cairo in led to my spending a sabbatical in his group at the Naval Medical Research Institute (NMRI) 
in Bethesda, Maryland, in 1976 and another short spell in 1979. These visits ultimately led to studies on 
tegument surface labelling and membranocalyx turnover. We also developed an existing freeze-thaw 
procedure to produce highly enriched tegument surface membranes (1983) but ways to characterise the 
surface molecular composition were still decades away.
Around 1975 we began to research the kinetics and route of migration that schistosome larvae took 
from the skin to the portal system. It was known that schistosomes left the skin and travelled to the lungs 
in the vasculature before somehow materialising in the portal tract. Our hypothesis that the schistosomula 
might take an entirely intravascular route, ϐirst elongating to crawl through vascular beds, was met with 
some incredulity. However, the labelling of cercariae with Se Seleno-methionine and their subsequent 
detection in compressed mouse tissues by autoradiography, some of the work carried out in collaboration 
with Drs Dean and Mangold at NMRI in 1983-1984, decisively settled the question of route and rate of 
parasite transit to the liver. The ramiϐications of this work continue to the present.
Concomitant immunity and death of invading parasites in the skin were the zeitgeist of the late 1970s 
and early 1980s. Based initially on experiments with rhesus macaques, it had been suggested that primary 
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worm burdens persisted, yet at the same time protected the infected host against invasion by further larvae. 
The paradigm was quickly extended to humans and to other laboratory hosts. The mechanism for parasite 
killing in vitro was elegantly dissected by several groups, who showed that newly transformed skin-stage 
schistosomula were highly susceptible to antibody-dependent cellular cytoxicity mechanisms. 
Very slowly over a period of years the story began to unravel. A vital piece of evidence was always lacking, 
namely the demonstration of dead and dying parasites in the skin of hosts with concomitant immunity. 
A rejected manuscript describing our failure to ϐind such dead parasites in a histopathological study of 
skin invasion in “immune” mice, still resides in my ϐiling cabinet! Another problem was that concomitant 
immunity, in mice at least, did not develop after infection with cercariae of one sex only, suggesting that 
it was associated with egg-induced pathology. Given our new knowledge on the kinetics and route of 
migration from skin to portal system, there seemed a very obvious explanation. The deposition of eggs in 
the liver was known to cause portacaval shunting. We reasoned that the shunts would provide a highway 
for newly arrived larvae to exit the portal system. With funds from the MRC we were able in the mid1980s 
to conϐirm the “leaky liver” hypothesis as the cause of “immunity” in mice with a chronic infection. The 
parasite tracking studies mentioned above, ϐinally demolished the concept of concomitant immunity in the 
chronic mouse model.
Building on our recently acquired knowledge of the tegument, migration and immunity, we turned to the 
use of attenuated cercariae as the basis for a schistosome vaccine. I had already worked at NMRI alongside 
Drs Minard and Dean, leading exponents of the model, as well as the people working with irradiated malaria 
sporozoites. The protective immunity induced in mice by exposure to attenuated cercariae appeared to 
provide an ideal system not associated with overt pathology. Collaboration with Dr Quentin Bickle (LSHTM) 
got us started with experiments, and led to the ϐirst quantitative demonstration that challenge parasites 
in vaccinated mice left the skin and migrated at least as far as the lungs; there they attracted effector foci 
of leucocytes whilst migrating along pulmonary blood vessels. Dr Brian Dixon in Leeds University gave us 
access to his Cobalt source and there followed a long period during which we characterised the mechanisms 
elicited in mice by radiation-attenuated cercariae and deϐined the underlying immunological processes 
leading to challenge elimination–in a nutshell, blocked migration not cytotoxic killing. The mediating 
antigens, however, remained elusive.
The relevance of the laboratory mouse to human schistosomiasis has often been disparaged. With that in 
mind, between 1996 and 2006, we took the irradiated vaccine model into primates, with funding from the 
European Commission. This involved collaborations with groups in Leiden, The Netherlands (Prof Deelder 
and Dr Van Dam), the Biomedical Primate Research Centre, Rijswijk (Drs Thomas and Langermans) and 
Kenya (Drs Reid, Yole, Kariuki and Farah) at the Institute of Primate Research, Nairobi. The outcome of 
these experiments was the demonstration that baboons, vervet monkeys and chimpanzees could all be 
protected against a live cercarial challenge by the irradiated cercarial vaccine. With multiple vaccinations, 
levels of protection>80% were achieved and although this protection waned with time, it was still >50% 
after three months. These data provide a sound basis for believing that a schistosome vaccine for human use 
is feasible, in spite of the fact that adult worms can reside for many years in the portal tract.
The 1980s were the golden decade for schistosome vaccines. Monoclonal antibodies became popular 
as a potential short-cut to identify vaccine candidates, while recombinant DNA technology made feasible 
both the rapid screening of immune sera for targets, and the production of the speciϐic proteins in quantity. 
The upshot was that several groups published data on their favoured candidates. Such was the fervour that 
around 1990, the TDR division at WHO, Geneva sponsored independent vaccine trials to identify the most 
promising candidate to take forward to humans; the York group was one of two laboratories invited to 
conduct the trials. In the event, six candidates were submitted, only one of which was a membrane protein; 
the other ϐive were either cytosolic or cytoskeletal in origin. Sufϐice it to say that in neither test laboratory 
did any candidate attain the benchmark 40% protection deemed essential for further development. 
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Nevertheless, the ramiϐications of this episode linger right up to the present day, with two of those original 
candidates still being talked about (and trialled). 
Whilst work with individual candidates has continued, there has been a slow realisation that for a 
schistosome vaccine to succeed, the target antigens must be accessible to the immune system in the live 
worm. This reorientation of approach has led the drive to characterise the parasite-host interface at a 
molecular level in penetrating cercariae, migrating schistosomula, and adult worms to identify the putative 
targets of immune attack, now a feasible goal due to the rapid advances in ‘omics’. The cloning of schistosome 
cDNAs got off slow start with only a few hundred sequences deposited on Genbank after a decade of work, 
almost all encoding abundant and immunogenic internal proteins. The major effort to increase coverage was 
spearheaded by Brasilian researchers, (Dr Franco in Belo Horizonte and Prof Verjovski in Sao Paulo). Thanks 
to hosting numerous Brasilian researchers over the years, we became involved in these EST sequencing 
projects at an early stage and York researchers spent signiϐicant periods in those cities. The culmination 
of this collaboration was the publication of the S. mansoni transcriptome in Nature Genetics in 2003, based 
on the analysis of 125,000 ESTs; at the time this seemed an enormous dataset. Subsequently we were also 
involved in the S. mansoni genome sequencing project with Drs Ivens and Berriman at the Wellcome Trust 
Sanger Institute and Drs LoVerde and El-Sayed in the USA. This exciting schistosome community effort 
resulted in the publication of the draft genome for S. mansoni in Nature in 2009. 
Around 2000 I attended a meeting in London where Dr Mark Blaxter remarked that no-one had yet used 
MALDI ToF on a helminth parasite. Never was a casual remark so opportune. Back in York, I asked Dr Peter 
Ashton about the technique. He came back with the full title “Matrix-Assisted Laser Desorption/Ionisation 
Time of Flight” mass spectrometry, to identify proteins in gels, and the news that we had free access to the 
latest instrument. We had used the O’Farrell method to separate tegument proteins in two dimensions on 
gels in the early 1980s but no simple method then existed to identify the many spots. Access to the Brazilian 
ESTs and a mass spectrometer led in 2004 to the ϐirst use of proteomics on a helminth to quantify the major 
constituents of four schistosome antigen preparations so beloved of immunologists. The establishment of a 
Proteomics laboratory in York meant we were well placed to perform compositional analyses of the cercarial 
secretions, the tegument surface, the vomitus regurgitated by adults and the secretions of live eggs. These 
are the major sources of protein input from the parasite into the host body. However, the composition of the 
membranocalyx has proved particularly intractable due to the lack of a robust method for its enrichment; 
this remains the key to understanding immune evasion in the bloodstream.
Returning to the work on schistosomes in primates, I had often wondered if the “concomitant immunity” 
displayed by rhesus macaques might be the result of portal caval shunting. (We had already identiϐied 
shunting as the cause of “immunity” in Rattus rattus, and in the 129 strain mouse). The opportunity to 
test this hypothesis was provided by a small EC grant that allowed us to infect six animals and then after 
about 20 weeks, to measure porta-caval shunting and recover the worms. Shunting proved minimal in ϐive 
monkeys but serendipity took a hand when Patricia Coulson noticed that the recovered worms were pallid, 
not the usual black colour. This opened up a whole new avenue of research that continues to the present. We 
showed that the surviving worms had stopped feeding and were slowly starving to death–we termed this a 
‘self-cure’ process. Initially we identiϐied antibody reactivities with gut and tegument proteins, but another 
twist was added to the story by our collaborators in China. In the mid-2000s Prof Liu and Dr Cao from the 
National Institute of Parasitic Diseases in Shanghai has visited York to learn proteomic approaches. In 2011, 
their colleague Dr Xiao Hong Li obtained funds to perform a rhesus macaque experiment with S. japonicum, 
but this time we were forewarned about what to expect. The same pattern of worm starvation and death 
was observed. 
This work led us to focus on the neglected schistosome esophagus as a potential source of antigens, 
with the realisation that is was much more than a food-conducting tube. Dr Li spent 2013 in York 
characterising the anterior and posterior esophageal glands and she showed that their secretions initiated 
blood processing. With the arrival of cheap sequencing technologies, we have now identiϐied about 40 genes 
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encoding secreted proteins, differentially expressed in the glands of both S. mansoni and S. japonicum; these 
proteins provide an entirely new cohort of vaccine candidates. Over the same period, the Brasilian ‘Science 
without Borders’ and ‘Newton’ programmes have maintained collaborations with researchers in Ouro 
Preto (Dr Castro Borges), Sao Paulo (Dr Leite & Prof Verjovski), Sao Carlos (Dr DeMarco) and Salvador (Dr 
Farias) and with Dr Ashton in York. These studies are aimed at linking our new knowledge on the exposed 
and secreted proteins of the parasite-host interface with the protective immune responses developed by 
rodents and primates exposed to irradiated cercariae and also in ϐinding the targets of the self-cure process 
in rhesus macaques. Will a schistosome vaccine emerge in the near future? A note of caution about vaccine 
testing in mice was sounded in our most recent publication. In our rodent experiments we always left ϐive-
week gap between the last exposure to attenuated cercariae and the challenge with normal cercariae. The 
point was to allow any responses elicited by the vaccine to return to baseline before the challenge parasites 
entered the host. In single antigen trials that gap has shrunk, usually to two weeks and sometimes to as little 
as ten days as more internal, even nuclear, proteins have been proposed as candidates. We have suggested 
that “protection” in such circumstances results from the diversion of migrating schistosomula into alveoli 
during migration not as the result of acquired immune responses, but as a bystander effect of vaccination. 
The wily schistosome still has the upper hand.
Dan Colley writes
These are discoveries about one’s self and about others around you and for me they have laid the 
foundations for everything else I have subsequently done (or not done) in the realm of what might be called 
scientiϐic discoveries. Many of these personal discoveries came early in my scientiϐic career, but many of 
them also “appeared” along the way and continue to pop-up at the age of 73.
The ϐirst of these underlying personal discoveries occurred in my ϐirst year in graduate school during a 
laboratory rotation with Dr. Cliff E. Dowell, working on the bacteriophage φX174 and Escherichia coli. The 
scientiϐic discovery had to do with making E. coli a temperature-sensitive host for the virus and while that 
was satisfying, the discovery I am describing here was the discovery that generating my own data, thinking 
about what those data meant, analyzing those data with the help of Dr. Dowell, presenting those ϐindings at 
a national ASM meeting and publishing those ϐindings felt really, really good. The discovery was realizing 
that I could do something original (obviously with the mentorship of someone who really knew what they 
were doing), think through the process and come up with something others saw as worthwhile. That was 
the discovery–and it felt good! [22].
One of the ϐirst things that I discovered in schistosomiasis was that eosinophils are beautiful and alluring. 
Then I learned that they are also a cruel mistress. I studied eosinophils because they were there, nobody 
knew what they did and they were beautiful. They were a cell-type in need of a function, they hung out in 
and around schistosome egg-induced granulomas (the primary object of my early studies), and they were 
beautiful. I worked out a way collect a lot of them and to measure their in vitro migration. This led me to 
describe a new lymphokine (now called cytokines) that I called Eosinophil Stimulation Promoter (ESP). It 
was an age of discovery for cytokines and if you found one you named it for the functional situation in which 
you found it. It was long before the term interleukin and lots of numbers came into vogue. My lymphokine 
made eosinophils crawl out of agarose droplets in 96 well plates, hence the name. Plus, I liked confusing 
it with Extra-Sensory Perception (ESP). Some of my friends even said it was appropriate because it was 
found in the “medium”. The name ESP stuck in the literature, that is, until one of my graduate students (W. 
Evan Secor) proved in 1990 that there was no ESP. Evan meticulously showed it was really a synergistic 
combination of IL-5 and GM-CSF produced by lymphocytes on antigenic stimulation. So my claim to fame 
for discovering a cytokine bit the dust and my heart was broken once again by eosinophils. Nevertheless, 
my laboratory studied them for a long time–during periods when they went in and out of favor. My joy in 
seeing them in exudates or tissue sections never diminished and while we still do not really know what they 
do, I don’t think it ever will [23,24].
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Another early discovery in my career was that sometimes you have a theory that leads to correlative data 
to support it, but it is really exciting when you develop direct evidence that something active is happening 
in a way that you envisioned it. Here I am talking about granuloma modulation-which my laboratory 
studied for many years in many ways. While we did a lot of studies and published a lot of papers about 
them with interesting ϐindings, it was one of the earliest that was the most exciting for me. It was when 
we did adoptive transfers of spleen or lymph node cells from mice chronically infected with Schistosoma 
mansoni (when newly formed anti-egg granulomas are smaller than earlier during infection) into mice with 
early (6 week) infections and then looked two weeks later when granulomas would usually be maximum 
in size. The hypothesis was that the diminution of newly formed granulomas in chronically infected mice 
was due to immunoregulation mediated by lymphocytes (then called suppressor T cells). The data showed 
that the adoptively transferred cells from chronically infected mice modulated the normally maximal 
granuloma formation in mice with early infections and the granulomas were smaller–like those in mice 
with chronic infections. This then opened the door to many, many more experiments to better deϐine the 
systems and how they worked, but it was this initial discovery that was so exciting to a young investigator 
establishing himself in a new ϐield [25]. Another fun discovery was instigated by a need to turn cercariae 
into schistosomules, i.e., the infectious form of schistosomes into the larval form that occurs immediately 
after the infectious form penetrates the skin. When cercariae penetrate the skin of a mammalian host they 
do so with a ϐlood of enzymes and wildly active whipping around of their tails, which break off, leaving their 
heads (or bodies) to penetrate and become schistosomules. A lot of interesting biology is involved in this 
process that instantaneously changes a water-tolerant animal into a saline-tolerant animal, but that was 
not my problem at the time. My problem was that I wanted to use schistosomules for some experiments 
and I need a way to make them from cercariae without the skin penetration part. I reasoned that maybe 
it was the breaking off of the tail that triggered the ability of the head/body of the cercariae to turn into 
schistosomules. I then thought that shearing forces might make this “tail breakage” happen without too 
much trauma to the head/body. I took some cercariae (shed from infected snails) and ran them up and 
down through a 22 gauge needle attached to a 10mL syringe. It broke off the tails and then if I put the heads/
bodies into saline-base culture media at 37C over-night, the head/bodies developed the characteristics of 
schistosomules. 
This was really exciting and with a graduate student (Stephen K. Wikel) we went on to show this in more 
detail and published it in Experimental Parasitology–one of my very few real parasitology publications. 
It was exciting and fun. This story also has two other fun parts. I chose Experimental Parasitology as the 
place I wanted to publish this because the editor (David Lincicome) was married to the “Queen of Cercariae 
and Schistosomules,” Peg Stirewalt. I knew that Peg would review it and the manuscript never make it 
to a publication unless Peg was convinced. Later Peg told me that when David gave it to her to review 
she immediately went in to her laboratory and reproduced the ϐinding–22 gauge needle and all–and then 
recommended its publication. I found that really, really cool. The other thing about this discovery is that 
someone else, at the same time, discovered a different way to make schistosomules, by vortexing cercariae 
to make them lose their tails. The person who did this is a very good friend of mine from Brazil, Juarez 
Ramalho-Pinto. Without knowing it we published our two ϐindings separately and at about the same time. 
About 40 years later (February 2016) I was in a meeting and heard two presentations that still used both of 
these methods (22 gauge needles and vortex mixers) to good effects to make schistosomules. Discovering 
something that is still useful decades later, that’s really fun and rewarding! [10].
Starting in 1975 and continuing to this day I discovered that you can do real immunology with real 
people. This started in St. Lucia, then Brazil and Egypt and now continues in Kenya. Maybe the most amazing 
part of this discovery was that immune responses by people infected with S. mansoni in all of these places 
are relatively reproducible from place to place, if your account for the person’s longevity of infection and the 
clinical stage of their infection. This was really a discovery for me and still amazes me, although I suppose it 
should not. The other, not so great discovery of working with human immunology was that you are pretty 
much stuck doing correlative studies rather than mechanistic studies. This is, of course, because you cannot 
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“experiment” with people in the same way you can manipulate or control mice or other experimental 
animals. Once you realize this difference it is ϐine, but it does take discovering or you will be frustrated. This 
means it is very difϐicult to prove something, but rather you settle for correlating outcomes to epidemiologic 
and clinical situations. It was also a major discovery for me to ϐind that pregnant women impact the immune 
responses and immune repertoires of their babies–and the same is true with dams and their offspring in 
mice. This is something that I believe needs much more investigative attention, but is not something that I 
will eventually ϐigure out. It will be something exciting for others to solve [26,27].
My minor adventures in investigating immune responses in human while our laboratory was studying 
Chagas disease is was also an exciting thing to show that there is T. cruzi DNA in the hearts from people who 
had cardiomyopathy and had died due to their Chagas disease. Until then most, but not all, investigators 
only supposed this was true. However, Elizabeth Jones, a Vanderbilt medical student who took a year off 
to work on this with us in Uberaba, Minas Gerais and Brazil was the one who ϐinally actually proved it was 
true. That was exciting for both the ϐinding and that it was Elizabeth who did it. After all, Carlos Chagas was 
a medical student when he discovered the entire life cycle of T. cruzi, so it was ϐitting and fun that Elizabeth 
Jones, another medical student, should actually demonstrate T. cruzi DNA in heart lesions of those with 
Chagas disease [28].
Back in the world of schistosomiasis, now collaborating with Evan Secor and Diana Karanja (of the 
Kenya Medical Research Institute, KEMRI) in Kisumu Kenya we did a longitudinal series of studies on men 
that were occupationally exposed to getting infected with S. mansoni as they washed cars or harvested sand 
in Lake Victoria. 
With the help of these men in Kisumu, we discovered something that, in that correlative way of human 
data, provided additional evidence that excretion of S. mansoni eggs across the gut wall is facilitated by an 
intact CD4 immune system. This was a particularly nice thing for me to ϐind because it was in support of a 
friend of mine’s (Raymond T Daminan’s) much earlier prediction. Ray based his hypothesis on morphologic 
evidence and a keen sense of the life of schistosomes. Others had also provided some evidence of this from 
mouse studies where you could take away the immune system of mice and see that infected, immunodeϐicient 
mice did not excrete eggs and giving them back immune cells allowed them to then excrete eggs. However 
we could not do that in people so we studied those unfortunate enough to have both schistosomiasis and 
HIV infection. It turned out that people who had the same levels of worm antigen in their circulation or their 
urine, meaning they had approximately the same number of worms, excreted lower numbers of eggs if they 
had lower numbers of CD4 lymphocytes, i.e., were more immunodeϐicient. We interpreted this as showing 
what Ray had predicted and Mike Doenhoff and others had shown in mice, namely that schistosomes 
cleverly co-opt their mammalian host’s immune system to complete an essential part of their life cycle, 
getting their eggs out into the environment where they could hatch and infect snails. It was exciting to ϐind 
this and gratifying to see that the predictions and experimental ϐindings of friends had a basis for the human 
situation [29]. 
Another exciting ϐinding in human immunology was when we, in Kisumu, provided evidence that 
over time and after many infections, treatments and reinfections for S. mansoni some people developed 
what we interpreted as increased resistance to reinfection. What we actually saw was that men who were 
occupationally exposed to high risks of reinfection, if treated every time they got infected, would, after 8 or 
9 treatments and reinfection, develop longer and longer times of exposure until their next reinfection. This 
was paralleled by an increase in their IgE antibodies against worm antigens and we think this is evidence that 
repeated treatment and reinfection can lead to immune mechanisms that help kill off incoming reinfecting 
cercariae. This has always been a very controversial area in human schistosomiasis so ϐinding what we 
believe is evidence of the development of resistance is signiϐicant. Of course continually treating and getting 
reinfections is a lousy way to think about vaccinating someone, but it could be taken as evidence that 
someday vaccine development might be achievable–given the right antigen(s) and the right adjuvant(s). 
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Someday. In any case, when the data from this 5 year, very laborious study were ϐinally analysed we were 
pretty excited at the ϐinding [30]. 
In the realm of public health immunology and in the setting of a consortium that I was asked to put 
together for the Bill and Melinda Gates Foundation called the Schistosomiasis Consortium for Operational 
Research and Evaluation (SCORE) my colleagues and I evaluated a new diagnostic or mapping assay for 
schistosomiasis mansoni called the Point-of-Care Circulating Cathodic Antigen assay (POC-CCA). This assay 
is done on urine instead of faces (which makes the specimen much easier to get and much less smelly to 
handle) and it can be done in the ϐield at the time of specimen collection. Basically, it is a lateral ϐlow cassette 
assay like a pregnancy test but for whether you have S. mansoni infection. The standard test for this is called 
the Kato-Katz test and has been used effectively for over 40 years. But it is insensitive and requires feces, a 
microscope and a well-trained technician. And it stinks. SCORE funded investigators in 5 different African 
countries to test the POC-CCA in parallel with the Kato-Katz to see how it would do. It did very well and it 
was more sensitive than the Kato-Katz, i.e., it found more cases of schistosomiasis [31]. 
This is a good news-bad news situation. If there are more cases you certainly want to ϐind them, but if 
you ϐind more cases it means controlling and getting rid of schistosomiasis is going to be harder than once 
thought. Also, there is, with any new assay that appears more sensitive than the old standby assay, the 
question of speciϐicity, i.e., is it picking up people who are not really infected? SCORE has done several more 
studies of the comparisons between Kato-Katz and the POC-CCA. It looks like it really is more sensitive and 
there really is more schistosomiasis than we thought. Maybe there is a lot more. Well that is not good news 
and not a reason to be excited and happy. However, it is a reason to be excited and realistic. If there is more 
we need to know that and up our game. How to do that is the next question. It is probably true that there is a 
lot more out there, but it is probably also true that many of those undetected by the Kato-Katz but detected 
by the POC-CCA have low levels of infection and therefore low levels of egg output. So what does that mean? 
Well it means we may need to make some challenging public health decisions about how important those 
low level infections are and what to do about them. It may boil down to what is your end goal–control or 
elimination? This is again part of that difϐicult excitement. It is a challenge and it is a meaningful challenge 
that has consequences for people and governments. It is all part of doing research that ϐinds meaningful 
answers and thus pushes new frontiers in what we think are important ways. 
I have also discovered over the course of more than 50 years of doing research for a living that the 
techniques and tools available change rapidly. This is great, but I have also learned that the main challenge is 
to ask real and appropriate questions using whatever tools are available in the time and place you are doing 
your research. When I started as a graduate student in immunology we did not know about T lymphocytes. 
Then in the major publication from my postdoctoral studies we called them “so-called T lymphocytes”. In 
my early faculty years we identiϐied them by Sheep Erythrocyte Rosettes and then CD3-postive lymphocytes 
and found that there were subsets of T lymphocytes many subsets. Still, no matter how you identify them, 
ϐind them, expand them or delete them, what really counts is whether you ask a meaningful question of 
them. 
I have graduated 18 PhD students and mentored many more. Training each and every one of them has 
lead me to another discovery. It will be the last one that I will write about in this overly long discourse. 
Graduate students from the USA, Brazil and Kenya, and I assume everywhere else, become real scientists 
when they have their own data upon which to cogitate, and not before. It is, actually, quite a simple discovery. 
You can guide graduate students through experiments, simple or complex, but it is only after they have 
amassed sufϐicient data to allow them to think about what it means and what it does not mean that they 
are truly engaged in the scientiϐic endeavour. I think this is fascinating and exciting. Once I discovered this 
I stopped trying to force them to think deeply about the whys and wherefores of their projects, and simply 
let it happen when the data started to ϐlow. Obviously some nudging at this point can be helpful, but it is one 
of the most joyous discoveries that I have known-watching that happen to one of my students, and knowing 
that it happens all over again for me, every time the data starts to ϐlow. It means I am very fortunate. 
022
JR Kusel, UK
ISBN: 978-81-943057-3-6
Personal experiences during discoveries in Schistosomiasis
doi: https://dx.doi.org/10.17352/ebook10114
Andreas ruppel writes
Science is exciting otherwise one should chose a different career. I was very excited from the beginning 
of my University study, but then felt that this is not enough. Instead of “playing chess” (at that time my work 
on bacteriophage genetics gave me that feeling), I wanted to contribute to solving real problems. I was 
extremely lucky to be accepted as doctoral student by Donato Cioli at the National Research Council in Rome, 
Italy. He was a source of inspiration and patient support on my search for what I considered meaningful 
science. At the end of my doctoral work, science continued to be exciting, but its meaning became rather 
elusive. I had worked for the aim to contribute to a vaccine, which was a very fashionable idea already in 
the early 70’s. Yet, despite many eminent scientists following that road, no one really hit the ground with 
something being protective against an infection with schistosome larvae (the cercariae).
I was too much focused, then, on the newly emerging ϐield of immunology to realize the importance of 
the very successful work with a highly protective irradiated cercariae “vaccine” being done with bovines 
by Majid and coworkers with Schistosoma bovis and Hsü and coworkers on S. japonicum, not to speak of an 
irradiated larvae vaccine against dog hook worms, which (to my knowledge) was the ϐirst protective vaccine 
ever already in the 60’s [32]. My own focus turned in the early 80’s to the interaction of the complement 
system with schistosomes, being given the chance to set up a laboratory in Heidelberg, Germany, thanks to 
Ursula Rother (a leading German “complementologist”) and Hans-Jochen Diesfeld (one of the then very few 
German scientists in tropical medicine, adventuring in thoughts of parasite immunology). The complement 
system was then high on the agenda and extrapolations from the bactericidal to an anticipated parasiticidal 
activity appeared as being exciting for a number of researchers in schistosome immunology. 
As a young newcomer in this ϐield and being somewhat isolated in Germany, I felt particularly glad and 
thankful for support by several schistosome researchers which I got to know at the Spring Meetings of 
the British Society of Parasitology and who responded to my great need for scientiϐically knowledgeable 
discussion partners. With some of them (John Kusel and Mike Doenhoff) I was privileged later to join in 
research consortia. They were among my key teachers who made me realize how important it is to share 
our professional expertise with young scientists in search for their future. Diane McLaren, author of the 
memorable yellow book on “the schistosome surface in relation to immunity” had the highest impact 
in the early 80ies on my scientiϐic search, research and fascination by becoming my ϐirst international 
collaboration partner. Our paper in the European Journal of Immunology [33], was the very best result 
that could have happened to me. It gave me conϐidence, I was happy and proud – and we reached a relevant 
conclusion: the complement system is not the searched-for magic immunological factor killing the invading 
schistosome larvae soon after infection. Schistosomes simply do not bother about an immune mechanism 
which is directed against bacteria.
While I was busy studying the complement system to reach this important negative conclusion, which 
was scientiϐically exciting by not really glorious, monoclonal antibodies were invented and molecular biology 
was born. It was time to join the new trend, in particular, since in Germany at that time both technological 
revolutions had not yet found their way into parasite immunology. Heidelberg University provided a 
supportive and fascinating scientiϐic environment, for which nowadays the terms of “center of excellence”, 
“light house” or the like would be used. So, in cooperation with colleagues in the Institute of Immunology 
and the Center of Molecular Biology, we got our monoclonal antibodies [34] and we got the interesting genes 
cloned. It looked ϐinally as leading to a solution of a real problem, as I had wished since 10 years earlier: 
This was again fascinating science but had the additional perceived potential to contribute to speciϐic and 
sensitive serodiagnosis of schistosomiasis. Our monoclonal antibody met all requirements, at that time, for 
speciϐicity and sensitivity, the target antigen was sequence-identiϐied as a cysteine proteinase and its origin 
from the schistosome gut placed it exactly in the center of the scientiϐic discussion of diagnostic antigens. 
Although this remained formally unpublished, in 1986 I performed Western blots in a village in Mali using 
heat-stable reagents and such basic equipment that, with the help of some curious young boys, we could 
produce diagnostic reactions on a village market place. Today we would call it point of care-testing.
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Diagnostics and vaccines both turned not only molecular, latest by the early 90’s, but also searched for 
deϐined antigens. “Deϐined” meant cloned, recombinant molecules and by implication these were individual 
proteins. In reality, these were single proteins, widely believed to be able to do “the job”, i.e. provide 
sensitive and speciϐic diagnostics or immunogenic and protective vaccines. The concept that a deϐined 
vaccine (or a cocktail of such) would be able to confer protection against a schistosome infection was so 
much dominant that it assumed a character of dogma. At least innumerable publications concluded that 
the respective gene of the respective publication represented a “candidate antigen” with either diagnostic 
or protective “potential”. I was no exception to this run for the golden bullet. Yet we have to accept–on 
a more modest view–that viruses with their very few genes and bacteria with plenty more, are not good 
“models” for schistosomes with their thousands of genes. The vaccine candidates of the 90’s, which had 
an international standing, all failed to reach the “stated goal of consistent induction of 40% protection or 
better” [35]. Antigens discovered and promoted in my own group [36], were no exception to this gloriously 
failed rush to the “poor men’s vaccine”. 
“Crude antigens” lacked the shine of molecular techniques, the belief in deϐined molecules and also 
lacked scientiϐic attractivity in the sense of “advanced technology”. Yet, crude antigens formed the ϐirst 
ever successful vaccine against a helminth (the dog hook worm), were effective in the early irradiated 
vaccines with Cobalt- irradiated S. bovis cercariae (irradiation performed in a central facility with Co 
source), cryopreserved (and thus transportable) schistosomula and UV irradiated cercariae (irradiated at 
the farmers place just before used for immunization [37]. This line of efϐicient vaccines remained poorly 
accepted and did not result in an applicable vaccine. 
Deϐined antigens recently made their way in to speciϐic and sensitive tests, even apt as point of care 
diagnostics. The antigens originated, not surprisingly in retrospective, from the schistosome gut, where they 
are produced “en masse” during the digestive process of schistosomes. Their early and massive production 
explains their advantage in the use for diagnostics over many other “diagnostic antigens”. Retrospectively, 
we may not have pushed hard enough by a sustained ϐlow of publications to promote the proteins identiϐied 
in my group 30 years ago as diagnostic antigens. However, other antigens made it to the point-of care- 
diagnostics; and this is the really positive aspect of an international search for suitable diagnostic antigens. 
The excitement of science made me enter schistosomiasis research and was a factor to keep me in this 
ϐield. Our research in schistosomiasis was even illustrated as “giants” among the German co-authorship 
networks in Neglected Tropical Diseases [38]. This ϐlatters a scientist’s ego. Yet this does by no means 
imply any substantial contribution to towards the goals that made me enter schistosomiasis research in 
1972. In 2009, Hotez and Fenwick reported the “alarming ϐinding that fewer than 5% of the world´s people 
with schistosomiasis are today receiving praziquantel that costs as little as 8 cents per tablet”. If I were to 
start research on schistosomiasis again, after over 40 years, today I would consult the practical guide on 
Implementation Research in Health [39] and ask what I now consider the most relevant question: “Why do 
we not implement, what we already know”?
Mike Doenhoff writes
I began my scientiϐic life was as a theoretical immunologist and in 1970 obtained a PhD for experimental 
work on the lymphocyte system of mice performed in Tony Davies’ lab at the Institute of Cancer Research 
in London. The 1960s were exhilarating times for cellular immunology and Davies and his colleagues, 
working on thymus-grafted chimaeric mice, made the important discoveries that the thymus seeded 
cells to peripheral lymphoid organs and that these cells divided in response to antigenic stimulation, but 
that they did not produce antibody [40]. My contribution was also heavily reliant on the thymus-grafted 
chimera and showed that the considerable number of mouse blood lymphocytes that divided in response to 
phytohaemagglutinin-stimulation in vitro were all thymus-derived, i.e., T cells [41]. 
After post-doc fellowships with Tony Davies, in 1975 I was offered a job working on schistosomiasis 
at the London School of Hygiene and Tropical Medicine (LSHTM). Mice immunosuppressed by T-cell 
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deprivation had been fundamental to our work in the Davies lab and while waiting for refurbished labs to 
be kitted out at LSHTM’s Winches Farm ϐield station in St Albans we began investigating the host/parasite 
relationship of S. mansoni in normal and T cell-deprived mice. An early observation, requiring very little in 
the way of sophisticated laboratory equipment, was unexpected–T cell-deprived mice excreted far fewer 
eggs in their faeces than normal mice [42,43]. We also showed that the S. mansoni-infected deprived mice 
suffered from a severe hepatotoxicity reaction [44], essentially the same observation as [45,46], had made 
earlier in athymic nude mice.
We began a search for the factors responsible for the apparent immune-dependence of schistosome egg 
excretion and the severe hepatotoxicity reaction in immunosuppressed mice. Passive transfer of antibodies 
enhanced the rate of egg excretion in the immunosuppressed mice [43], so it was inferred that an (egg) 
antigen or antigens induced those antibodies: However, no single antigen has yet been implicated in the 
phenomenon. Experiments with S. mansoni and S. bovis, involving transfer of immune cells and serum 
to infected deprived mice, showed that the rate of schistosome egg excretion of both parasite species 
correlated numerically with the diameter of egg granulomas in the livers of the recipient mice [47]. The 
process of extravasation of eggs and their passage through intestinal tissue to the gut lumen is undoubtedly 
complex, and appears also to involve blood platelets [48], the latter probably in the initial adherence of the 
egg to the endothelial surface. 
As demonstrated ϐirst by [49], the S. mansoni egg granuloma is an immune (delayed hypersensitivity-
type) response, but no single schistosome antigen has been identiϐied as the causative agent: Rather, a 
complex of glycoconjugates may be responsible (van der Vijver et al., 2006). The hepatotoxicity that 
occurs in the absence of granuloma formation in immunosuppressed mice intuitively led to the conclusion 
that granulomas protected host tissue against toxic egg products [45,46]. Paradoxically, however, 
immunosuppressed mice with heavy S. bovis infections suffer no such hepatotoxicity and in fact survived 
longer than comparably-infected immunologically-intact controls [50]. Literature on the much-studied 
schistosome egg granuloma nevertheless still commonly implies that protection of host tissue is an 
important function of this cell-mediated immune response, though the results of an attempt to compare 
the relative hepatoprotective effects of transferred immune cells and immune serum in S. mansoni-infected 
deprived mice suggested the latter was more effective [51]. Promotion of schistosome egg excretion (and 
thus enabling continuation of the parasite’s life-cycle) may therefore be the prime biological function of the 
schistosome egg granuloma [47] and immune-facilitated dispersion of infection may be a feature that this 
infectious disease has in common with tuberculosis [52]. 
A search for the S. mansoni egg antigen responsible for the hepatotoxicity reaction in infected, 
immunosuppressed mice was more successful. Small volumes of sera from S. mansoni-infected mice and 
mice immunized with S. mansoni eggs could protect the livers of infected, immunosuppressed recipients 
and examination of immunoprecipitating antibody patterns in the hepatoprotective sera indicated that S. 
mansoni egg antigen omega-1 was the likely hepatotoxin [53]. 
During the course of the experiments to identify the hepatotoxin cation-exchange chromatography 
was used to prepare six fractions from S. mansoni egg homogenate. Samples of each of the fractions were 
forwarded to Chris Draper and colleagues at what was then the Ross Institute of LSHTM to test for sensitivity 
and speciϐicity in detection of human anti-schistosome antibodies in enzyme-linked immunosorbent assay 
(ELISA). The sixth cation exchange fraction (CEF-6) containing omega-1 and another antigen we named 
alpha-1 [53], was found to give the best serodiagnostic results in terms of sensitivity and speciϐicity and 
intensity of reactivity with human S. mansoni infection sera [54]. The result was consistent with the 
observation that in western immunoblots such sera had antibodies which reacted with only omega-1, 
alpha-1 and a third antigen, kappa-5 (Hamilton et al., 1998). 
In 1980-1981 the World Health Organization (WHO) organized an interlaboratory collaborative 
trial of antigens for immunodiagnosis of schistosomiasis. CEF-6 performed well as one of a panel of 21 
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S. mansoni antigens and immunoassay combinations that the WHO trial tested: it gave 91.7% sensitivity 
and 90.0% speciϐicity in ELISA, ‘demonstrated a high degree of sensitivity and speciϐicity’ in an indium 
slide immunoassay, was the only preparation to give a signiϐicant positive correlation between the ELISA 
absorbance value and faecal egg count, and gave the highest rate of conversion towards sero-negativity 
after chemotherapy [55]. Despite its success in the WHO trial and demonstrations of potential usefulness 
in the ϐield [56,57] and clinic [58], CEF-6 is not used in routine diagnosis of human schistosomiasis by 
antibody detection, perhaps because it is too costly compared with unfractionated S. mansoni soluble egg 
antigens (SmSEA) which are now in relatively common use in ELISA. 
During the 1980s and 1990s our work on the two antigens in CEF-6 led to reϐined methods for 
their puriϐication and furthered their characterization [59,60]. This was of course the period in which 
immunological research was transformed by the Th1/Th2 paradigm [61,62], the immunology of parasitic 
infection being also profoundly affected by this revolution. 
Many studies have now shown that S. mansoni eggs confer a strong Th2 bias on immune responsiveness 
[63]. Early in 2002, however, I received a draft manuscript written by Gabi Schramm and Helmut Haas 
(Borstel Research Institute, Germany) describing an interleukin-4-inducing factor (named IPSE) that they 
had puriϐied from S. mansoni eggs and which had the novel property of activating basophils to release the 
Th2 cytokine IL-4 via interaction with cell surface-IgE in a non-antigen-speciϐic way. To my surprise I was 
listed as an author and on enquiring why, was informed that this was because I had supplied S. mansoni eggs 
from which mRNA had been extracted and the gene for IPSE cloned and expressed, a transaction that I had 
long forgotten about. 
Results of polyacrylamide gel and western blot analyses of IPSE in this paper [64], were very reminiscent 
of the dimeric structure of alpha-1 [60], one of the two antigenic constituents of CEF-6 that we had identiϐied 
in SmSEA some 20 years earlier [53]. A collaborative study conϐirmed that Borstel’s IPSE was indeed the 
same as our alpha-1, hence the current name for this molecule: IPSE/alpha-1 [65]. The evidence that IPSE/
alpha-1 has an inherent Th2-biasing effect was consolidated by demonstrating its activity in vivo (Schramm 
et al., 2007). IPSE/alpha-1 is a new member of the βγ-crystallin superfamily of proteins and is considered 
to activate basophils via its unique IgE-binding crystallin fold [66].
Omega-1, the hepatotoxic S. mansoni egg antigen in CEF-6, has also been cloned and expressed in 
recombinant form and has homology with the T2 family of ribonucleases [67]. This molecule also has a 
potent Th2-conditioning effect in vitro and in vivo, mediated through its activity on dendritic cells [68]. The 
gene for kappa-5, the third immunodominant antigen in SmSEA, has likewise been cloned and expressed 
[69], but its role in the S. mansoni host-parasite relationship is not known. 
IPSE/alpha-1, omega-1 and kappa-5 are glycosylated and their respective glycanic constitutions 
have been analysed. The N-glycosylation sites of both IPSE/alpha-1 [70] and omega-1 [71], carry core 
difucosylated diantennary glycans with one or more Lewis X motifs in the antennae. The glycosylation of 
kappa-5 is distinct from that of the other two SmSEA molecules, as it comprises unique triantennary glycans 
composed of both difucosylated and xylosylated core regions and immunogenic GalNAc1–4GlcNAc (LDN) 
termini [72]. As mentioned above, glycoconjugate complexes may be responsible for granuloma induction 
(van der Vijver et al., 2006), but the extent to which the glycosylation of these three SmSEA molecules are 
involved in granuloma formation has not yet been studied.
Frank Cox writes about heterologous immunity
In the 1960s and 1970s I was working in the Zoology Department at King’s College London where my lab 
was interested in immunity to blood parasites in rodents and where we maintained six different species of 
intraerythrocytic protozoa in mice and frozen aliquots. Four were malaria parasites as possible models for 
human malaria and two were piroplasms as possible models for the cattle disease, babesiosis.
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We had already established, not unexpectedly, that infection with a particular species protected against 
the same species (homologous immunity) but also that in each of the pairs, (Plasmodium yoelii (Py)/P. 
berghei (Pb), P. chabaudi (Py)/P. vinckei (Pv) and Babesia microti (Bm)/B. rodhaini (Br)) mice that had 
recovered from infection with the avirulent species (the ϐirst in each pair) were protected to a greater or 
lesser extent against the virulent form (heterologous immunity) [73]. We then began to look for shared 
antigens and the possibility that antigens from a virulent parasites might be a basis of a vaccine to protect 
mice against virulent parasites. Our dream was to use this information for the development of a vaccine to 
protect humans against infection with the most dangerous malaria parasite, Plasmodium falciparum.
It was then that we discovered the most unexpected result: heterologous immunity between parasites 
belonging to different genera. It all began by accident. One Friday night it was my responsibility to test 
some frozen aliquots for viability. I had had a very busy teaching day so by the time I got to lab everyone 
else in the team had left leaving me with cages of mice that my technician had prepared and labelled. On 
the following Monday, we were surprised to discover that the mice injected with the virulent parasite, P. 
vinckei, showed no parasites but when we retested the same aliquot the mice all became infected. I was 
then told that the mice that had not become infected were not actually clean mice, as they should have been, 
but were mice that had recovered from the avirulent piroplasm, B. microti. Acting on a hunch, I set up a 
controlled experiment in which we infected mice that had recovered from B. microti with P. vinckei but none 
became infected. It then dawned on us that we had discovered that heterologous immunity between blood 
parasites was not conϐined to the genus Plasmodium but extended to a distantly related genus, Babesia, thus 
challenging the central tenet of immunology that immunity to one organism was speciϐic to that organism. 
We carefully repeated these experiments again with the same results and sent off a paper to Nature which 
they published immediately [74]. 
One of the most inϐluential parasite immunologists in the UK, Professor Sydney Cohen FRS, told us that 
our experiments had ‘turned immunology on its head’ and encouraged us to embark on a long series of 
cross-immunity experiments that extended our earlier investigations. Another person who was interested 
in our results was an Australian immunopathologist, Ian Clark, then working at the Royal College of 
Surgeons a few minutes’ walk from King’s College, who was interested in non-speciϐic immunostimulation. 
Among the immunostimulants he was using was BCG. We then injected mice with BCG by various routes 
and challenged with them P. vinckei, P. yoelii, B. rodhaini or B. microti and found protection similar to that 
that we had described in the heterologous immunity experiments: another paper to Nature [75]. BCG is a 
living immunostimulant so we repeated the experiments with a killed organism, Corynebacterium parvum, 
with much the same results and extended our studies to other immunostimulants and began to think about 
the possibility of non-speciϐic immunisation as a weapon against malaria [73]. 
We had now established that immunity to certain blood parasites could be induced by infection with a 
heterologous organism or by immunostimulants so we needed to understand the mechanisms involved. One 
clue came from the fact that Ian Clark, using light- and electron- microscopy, had observed that during the 
recovery phase of the B. microti infection parasites were seen to be dying within the red cells, observations 
that we repeated. We surmised that this was due to low molecule substances diffusing across the red cell 
membrane and Ian Clark suggested that these might be reactive oxygen intermediates (ROI), superoxides, 
peroxides and hydroxyl radicals, or reactive nitrogen intermediates (RNI). At this stage, we discovered that 
the generation of these toxic molecules actually did as much damage to the host as to the parasite. We then 
realised that we not going to get funding to further this line of research and dreams of a trip to Stockholm 
quickly evaporated.
Heterologous immunity is now known to be a more widespread phenomenon than we had expected and 
the rest of this chapter will concentrate on schistosomiasis. George Nelson (one of Leiper’s successors as 
Professor at the London School of Hygiene and Tropical Medicine) and his colleagues found a considerable 
amount of heterologous immunity between Schistosoma spp. For example, in mice infected with Schstosoma 
bovis or S. matthei subsequent S. mansoni infections were reduced by 75%-85% but S. bovis did not protect 
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against S. matthei [76] and later that S. haematobium did not protect mice against S. mansoni. Over the next 
ϐive years Nelson’s team wrote a series of papers under the heading Studies on Heterologous Immunity in 
Schistosomias, well worth reading in full, that extended these studies to other species of Schistosoma and 
other hosts including monkeys and baboons. 
Heterologous immunity between more distantly related organisms and schistosomes has received 
very little attention. One publication predates the experiments described above. In voles co-infected 
with Schistosoma mansoni and Plasmodium berghei the malaria infections were enhanced when both 
infections were given within two weeks of each other but depressed when the mice were infected with the 
malarial parasite seven weeks after infection with the schistosome [77]. Among the relatively few similar 
investigations, Plasmodium chabaudi infections in mice were enhanced in mice when the schistosome 
was given eight weeks earlier, Trypanosoma cruzi infections were more severe in mice infected with S. 
mansoni as were infections with Toxoplasma gondii, Entamoeba muris, Trichomonas muris and Spironucleus 
muris and in hamsters subsequently infected with Leishmania infantum [78], for more information and 
references. These experiments suggested that mice experienced a phase of immunodepression following 
infection with schistosomes, now a well-known phenomenon and that this inhibited the ability of the host 
to mount an effective immune response against subsequent infection with protozoa. The reciprocal is also 
the case: Infection with Plasmodium yoelii inhibited the development of schistosome granulomas in mice 
and also in the T. gondii/S. mansoni combination. As granuloma formation in both these cases results from 
enhanced immune responses the assumption must be that the protozoan infection depresses the immune 
response to subsequent infections with heterologous organisms [78,79]. 
This is not the place to discuss the mechanisms involved in heterologous immunity, nor to extend this 
discussion to include viral or bacterial infections, but the important point is that, in humans and other 
animals, exposure to unrelated infections can determine the outcome of subsequent schistosome infections. 
In the wild there cannot be many, if any, hosts that have not been, or have harboured another infection and 
that this is something that should be taken in to account in any ϐield studies. This seems to be rich vein that 
needs to be mined and Leiper would probably have agreed. 
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We can see from these accounts of personal experiences that there is a very great variety of 
conditions that motivate and excite the research worker and these relate to the personality of 
the scientist concerned. Leiper worked with a logical method and at times good relationships 
with colleagues, such as Atkinson, were put at risk. He valued painstaking observation and 
would always recommend “another closer look”. Dogmas need to be challenged and Leiper 
did this in his approach to the ideas of Loos, who denied that there was an intermediate host 
in schistosomiasis. Wilson very carefully challenged the dogmas of concomitant immunity 
and good laboratory observations, such as those of his colleague Coulson that worms from 
monkeys were pallid, led to a breakthrough in studying the feeding habits of the schistosome. 
Vieira, Cox and Kusel describe that chance ϐindings in the laboratory to have played a big part 
in their research. They also describe the crucial impact of having students working in the 
laboratory. Colley stresses that good colleagues with whom ideas can be readily discussed have 
played essential parts in the research. Cioli has a clear and logical approach to the mechanism 
of action of hycanthone and Livia Pica-Mattoccia has been an important colleague and friend. 
Coelho similarly has a well-designed project on snails resistant to miracidia of S. mansoni and 
friendships with colleagues contributed greatly to the success of the project which took decades 
to complete. Harnett describes the excitement of experiments using a newly developed assay. He 
also ϐinds the inspiring university teaching of Adrian Hopkins to have changed his career path. 
Ruppel uses immunodiagnostic methods in very challenging ϐield conditions in a Mali market-
place, helped by inquisitive young boys! Ruppel also makes the important point that, at the time, 
the scientist works on the accepted methods and paradigms. It is only with hindsight that he/she 
ϐinds that these paradigms have been misleading. However, the mind that constantly challenges 
is in danger of being unendingly critical. Doenhoff has a great ability to challenge accepted ideas 
and his imagination and persistance ends his account here with a possible explanation of the 
hygiene hypothesis. Colley describes the importance of guiding students carefully into research 
by getting their own results and allowing their own interpretations. Colley recognised the beauty 
of the eosinophil, Cioli felt awe and admiration of the parasite and Kusel saw wonder when 
observing the ϐlame cell of the excretory system in the egg and the adult worm. All our scientists 
found this beauty in working with the living parasite. This feeling is essential for sustained work 
and progress in any project.
What other things have we learned from these discourses? Students have always been an 
important factor in the history of the discovery.
The stimulating effects of students in the laboratory has been described by [80] and 
current attempts to separate teaching from research in Universities is a ϐlawed and superϐicial 
understanding of both. We have attempted to describe our experiences in scientiϐic research 
3 DISCUSSION, CONCLUSIONS 
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much as indicated by [82-85]. The creative worker is an adventurer, an explorer and has a close relationship 
with the object being studied. There is a spiritual dimension to all the work, especially during discovery.
We will end our stories with advice to our grand-children: Love your subject and show love for others. 
Always travel with humility. If you have an idea, try it out immediately, form good friendships and never 
denigrate others, immerse yourself in a problem and feel free to discuss it with anyone, and follow your 
results. Never give up. When you make a discovery never be arrogant and have a wider vision of creative 
work. Never be persuaded that religious feelings are separate from those seen during scientiϐic investigation. 
Both are founded on wonder and love.
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We would like to thank the Glasgow University “Scottish Encounters with Tropical disease” 
which hosted the Symposium on Leiper and Leishman in January 6th 2016. Mike Barrett and 
Vicky Curtis were especially supportive. I should like to thank my friends John and Maire Clegg, 
with whom I have spent time recently discussing Leiper (Leiper examined John’s PhD thesis!). 
Many thanks to our friends John and Kathie Lauder for memories of the Sudan during our visits 
to Stanton St. John, Oxford.
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